Abstract
Long-Term Results from a Phase 1b Study of Avadomide in Combination with Obinutuzumab in Patients with Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have